SeaBridge Investment Advisors LLC decreased its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 4.0% during the fourth quarter, according to the company in its most recent filing with ...
Colorado joined the federal government and 38 other states and territories to settle with Pfizer over alleged migraine drug ...
The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...
Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...
BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio raised $600 million combined and Allakos laid off staff.
In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...
Pfizer subsidiary Biohaven allegedly gave physicians speaker honoraria and meals at high-end restaurants to induce them to ...
A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...
Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...
Biohaven is accused of giving health care providers cash and lavish meals to get them to prescribe Nurtec ODT, a migraine ...
Attorney General Mike Hilgers announced Tuesday, Nebraska has joined the United States, 37 other states, and Puerto Rico to ...
A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback